PUMA BIOTECHNOLOGY Executives Sell Shares Amid Market Volatility.

PUMA BIOTECHNOLOGY, INC. (PBYI) has recently disclosed that one of its directors, President and CEO Alan H. Auerbach, has sold 16,938 shares at a price of $5.84 per share on January 6, 2026. Additionally, on the following day, January 7, 2026, Auerbach sold an additional 18,012 shares at $5.88 per share. Furthermore, the company's Senior Vice President of Regulatory Affairs, Douglas M. Hunt, has sold 3,973 shares at $5.84 per share on January 6, 2026, and 5,014 shares at $5.88 per share on January 7, 2026. Meanwhile, Chief Financial Officer Maximino F. Nougues has sold 4,540 shares at $5.84 per share on January 6, 2026, and 6,405 shares at $5.88 per share on January 7, 2026.